Hasten Biopharmaceutical
CBC-Backed Hasten Biopharmaceutical acquires 14 Celltrion Legacy products
Singapore-based healthcare-dedicated asset management firm CBC Group announced that its controlled portfolio company, Hasten Biopharmaceutical (Hasten), an innovation-driven biopharmaceutical company, has successfully acquired the asset rights of 14 branded products across Pan-Asia countries and regions from Celltrion, a South Korean biopharmaceutical…
